This is a news story, published by MSN, that relates primarily to the U.S. Centers for Disease Control and Prevention news.
For more disease research news, you can click here:
more disease research newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Alzheimer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest amyloid beta production news, Aβ accumulation news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
amyloid betaNewsweek
•78% Informative
Neuroscientists have made an exciting breakthrough in our understanding of Alzheimer's disease.
The discovery offers new, promising targets for Alzheimer's therapies to more effectively slow disease progression.
Alzheimer's affects roughly 5.8 million Americans , according to the U.S. Centers for Disease Control and Prevention .
VR Score
76
Informative language
74
Neutral language
23
Article tone
semi-formal
Language
English
Language complexity
63
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
4
Source diversity
2
Affiliate links
no affiliate links